Atlas Trials

[18F]F-AraG PET Imaging in Alzheimer's Disease

Clinical trial NCT07611357 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07611357
Sponsor
CellSight Technologies, Inc.
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Alzheimer Disease (AD)
Start date
2026-05-16
Primary completion
2029-09-16
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.